Marksans Pharma Limited
Name in FDA records: MARKSANS PHARMA LIMITED
NDC labeler code: 25000
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- PregabalinLyrica, Lyrica CR · 8 products
- Metformin hydrochlorideGlumetza · 5 products
- FluoxetineProzac · 3 products
- GabapentinNeurontin, Gralise, Relgaabi · 3 products
- NaproxenNaprelan, Rugby All Day Relief · 3 products
- DuloxetineDrizalma Sprinkle · 3 products
- ParicalcitolZemplar · 3 products
- IbuprofenIbu, Caldolor · 3 products
- Benzonatate2 products
- Dutasteride1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| March 30, 2026 | ANDA220298 | Benzonatate BENZONATATE | Pharmazone |
| July 18, 2022 | ANDA216197 | Pregabalin PREGABALIN | Pharmazone |
| April 7, 2017 | ANDA204376 | Dutasteride DUTASTERIDE | Pharmazone |
| October 7, 2016 | ANDA204948 | Paricalcitol PARICALCITOL | Pharmazone |
| April 29, 2016 | ANDA090295 | Metformin hydrochloride METFORMIN HYDROCHLORIDE | Pharmazone |
| December 11, 2013 | ANDA090723 | Duloxetine DULOXETINE HYDROCHLORIDE | Pharmazone |
| March 12, 2012 | ANDA090888 | Metformin hydrochloride METFORMIN HYDROCHLORIDE | Pharmazone |
| July 21, 2011 | ANDA090007 | Gabapentin GABAPENTIN | Pharmazone |
| February 14, 2011 | ANDA091416 | Naproxen NAPROXEN | Pharmazone |
| December 21, 2010 | ANDA090796 | Ibuprofen IBUPROFEN | Pharmazone |
| January 29, 2002 | ANDA075465 | Fluoxetine FLUOXETINE HYDROCHLORIDE | Pharmazone |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2018
-
January 9, 2018 · Class II · Terminated · D-0239-2018 · Ibuprofen
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Ibuprofen Tablets, USP 600 mg, 6 x 2500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403
-
January 9, 2018 · Class II · Terminated · D-0240-2018 · Ibuprofen
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Ibuprofen Tablets, USP 800 mg, 6 x 1900 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403
-
January 9, 2018 · Class II · Terminated · D-0238-2018 · Ibuprofen
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Ibuprofen Tablets, USP 400 mg, 6 x 3500 Tablets bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026